. 2011 Oct 14;12(10):6781–6795. doi: 10.3390/ijms12106781

Table 2.

Association between Lewis(y) and IGF-1R expression, expression intensity and pathological features in ovarian cancer.

Features		Case	Lewis(y)					IGF-1R

			Positive Cases	Rate (%)	P	MOD	P	Positive Cases	Rate (%)	P	MOD	P
Pathological type	Mucous	30	26	86.67	>0.05	0.463 ± 0.068	>0.05	24	80.00	>0.05	0.418 ± 0.044	>0.05
Pathological type	Serous	30	27	90.00	>0.05	0.477 ± 0.016	>0.05	27	90.00	>0.05	0.437 ± 0.051	>0.05
FIGO stage	I–II	39	33	84.62	>0.05	0.455 ± 0.065	<0.05	33	84.62	>0.05	0.413 ± 0.047	<0.05
FIGO stage	III–IV	21	20	95.24	>0.05	0.505 ± 0.072	<0.05	18	85.71	>0.05	0.444 ± 0.051	<0.05
Differentiation level	High	21	17	80.95	>0.05	0.448 ± 0.017	<0.05 ^*	16	76.19	>0.05	0.412 ± 0.052	<0.05 ^*
	Middle	21	18	85.71		0.461 ± 0.054	>0.05 ^†	18	85.71		0.413 ± 0.038	<0.05 ^†
	Low	18	18	100		0.498 ± 0.084	>0.05 ^‡	17	94.44		0.455 ± 0.049	>0.05 ^‡
Lymphatic metastasis	No	48	41	85.42	>0.05	0.459 ± 0.078	>0.05	40	83.33	>0.05	0.420 ± 0.054	>0.05
Lymphatic metastasis	Yes	12	12	100	>0.05	0.476 ± 0.057	>0.05	11	91.67	>0.05	0.433 ± 0.060	>0.05

Compared the low- with high-differentiation groups;

^†

Compared the low- with middle-differentiation groups;

^‡

Compared the middle- with high-differentiation groups.